Secondary outcome | Graded Activity (N = 58) | Supervised Exercise Therapy (N = 63) | Control (N = 59) | Group comparison | |||||
---|---|---|---|---|---|---|---|---|---|
GA vs Control | SET vs Control | GA vs SET | |||||||
Mean difference (95% CI) | p value‡ | Mean difference (95% CI) | P value‡ | Mean difference (95% CI) | p value‡ | ||||
RMDQ (0 = best, 24 = worst) | |||||||||
Baseline | 8.7 (4.9) | 9.3 (6.0) | 10.4 (6.1) | ||||||
Post-intervention | 4.1 (3.1) | 5.0 (4.9) | 9.9 (6.2) | −5.81 (−8.02 to −3.61) | < 0.0001*** | −4.91 (− 7.08 to − 2.74) | < 0.0001*** | −0.90 (− 3.06 to 1.26) | 0.939 |
3 month | 3.1 (2.4) | 4.7 (4.4) | 9.0 (5.7) | − 5.89 (− 7.87 to − 3.92) | < 0.0001*** | − 4.33 (− 6.27 to −2.39) | < 0.0001*** | −1.57 (− 3.50 to 0.36) | 0.154 |
6 month | 3.0 (2.3) | 5.5 (4.2) | 9.6 (6.0) | −6.59 (− 8.59 to − 4.59) | < 0.0001*** | − 4.07 (− 6.04 to − 2.11) | < 0.0001*** | −2.52 (− 4.48 to − 0.56) | 0.007** |
ROM – E (°,higher score best) | |||||||||
Baseline | 19.1 (5.7) | 17.8 (5.5) | 17.8 (5.8) | ||||||
Post-intervention | 23.7 (6.5) | 20.8 (5.7) | 17.7 (5.2) | 6.0 (3.3 to 8.6) | < 0.0001*** | 3.1 (0.6 to 5.6) | 0.010** | 2.8 (0.3 to 5.4) | 0.026* |
3 month | 24.5 (6.0) | 20.6 (5.1) | 18.0 (5.4) | 6.5 (4.0 to 9.0) | < 0.0001*** | 2.6 (0.2 to 5.1) | 0.031** | 3.9 (1.5 to 6.3) | < 0.0001** |
6 month | 23.8 (6.7) | 20.5 (6.1) | 17.8 (5.2) | 5.9 83.2 to 8.6) | < 0.0001*** | 2.6 (0 to 5.3) | 0.054 | 3.3 (0.6 to 5.9) | 0.009** |
FTF (cm, higher score worst) | |||||||||
Baseline | 13.0 (12.0) | 12.2 (12.9) | 13.1 (13.1) | ||||||
Post-intervention | 8.2 (9.6) | 9.8 (11.9) | 13.5 (12.8) | −5.34 (− 10.49 to − 0.19) | 0.039** | −3.74 (−8.80 to 1.33) | 0.230 | − 1.61 (−6.65 to 3.44) | 1.000 |
3 month | 6.4 (9.1) | 8.9 (11.3) | 12.7 (12.5) | −6.27 (− 11.22 to − 1.32) | 0.008*** | −3.73 (−8.61 to 1.14) | 0.197 | − 2.53 (−7.39 to 2.32) | 0.626 |
6 month | 6.1 (9.3) | 9.0 (11.1) | 13.2 (12.5) | −7.07 (− 12.00 to − 2.15) | 0.002*** | −4.18 (−9.02 to 0.67) | 0.116 | − 2.90 (− 7.72 to 1.92) | 0.444 |
PDSLRT (s, higher score best) | |||||||||
Baseline | 22.5 (25.3) | 22.0 (19.8) | 21.8 (20.3) | ||||||
Post-intervention | 98.4 (58.4) | 44.8 (32.9) | 30.9 (23.3) | 67.59 (47.99 to 87.18) | < 0.0001*** | 13.91 (−26.15 to −1.67) | 0.022** | 53.67 (33.04 to 74.30) | < 0.0001*** |
3 month | 97.0 (59.3) | 40.9 (29.1) | 30.4 (23.8) | 66.59 (46.69 to 86.48) | < 0.0001*** | 10.47 (−0.95 to 21.90) | 0.080** | 56.11 (35.73 to 76.50) | < 0.0001*** |
6 month | 107.1 (73.4) | 40.8 (31.3) | 23.9 (23.3) | 83.18 (59.16 to 107.20) | < 0.0001*** | 16.84 (5.00 to 28.68) | 0.003** | 66.34 (41.65 to 91.04) | < 0.0001*** |
SF-12 Physical (%, 0 = worst, 100 = best) | |||||||||
Baseline | 37.5 (7.4) | 38.2 (8.3) | 36.2 (8.7) | ||||||
Post-intervention | 46.7 (6.2) | 44.3 (6.8) | 36.8 (8.3) | 9.97 (6.76 to 13.19) | < 0.0001*** | 7.53 (4.24 to 10.83) | < 0.0001*** | 2.44 (−0.36 to 5.25) | 0.101 |
3 month | 47.4 (7.1) | 44.1 (7.6) | 36.5 (7.7) | 10.85 (7.60 to 14.10) | < 0.0001*** | 7.59 (4.29 to 10.89) | < 0.0001*** | 3.26 (0.10 to 6.42) | 0.042** |
6 month | 46.9 (7.1) | 40.6 (7.2) | 38.0 (8.5) | 8.92 (5.49 to 12.34) | < 0.0001*** | 2.67 (−0.73 to 6.07) | 0.154 | 6.25 (3.19 to 9.31) | < 0.0001*** |
SF-12 Mental (%, 0 = worst, 100 = best) | |||||||||
Baseline | 46.6 (9.4) | 46.7 (9.4) | 45.6 (10.5) | ||||||
Post-intervention | 52.8 (5.9) | 49.8 (8.5) | 45.2 (9.1) | 7.55 (4.17 to 10.93) | < 0.0001*** | 4.56 (0.76 to 8.37) | 0.014** | 2.99 (−0.15 to 6.12) | 0.065 |
3 month | 53.6 (6.2) | 49.9 (7.8) | 46.4 (9.1) | 7.19 (3.77 to 10.61) | < 0.0001*** | 3.51 (−0.15 to 7.18) | 0.064 | 3.68 (0.65 to 6.70) | 0.013** |
6 month | 53.0 (6.2) | 46.4 (8.5) | 46.2 (8.3) | 6.72 (3.48 to 9.95) | < 0.0001*** | 0.15 (−3.48 to 3.79) | 0.994 | 6.56 (3.37 to 9.76) | < 0.0001*** |
FABQ Work (0 = best, 42 = worst) | |||||||||
Baseline | 22.3 (5.3) | 21.6 (7.3) | 21.6 (9.5) | ||||||
Post-intervention | 14.6 (6.5) | 17.5 (8.8) | 20.6 (9.7) | −6.06 (−9.71 to −2.41) | < 0.0001** | −3.13 (−7.14 to 0.88) | 0.157 | −2.93 (−6.23 to 0.37) | 0.093 |
3 month | 11.4 (7.9) | 18.3 (9.5) | 19.8 (9.6) | −8.40 (−12.29 to −4.52) | < 0.0001*** | −1.48 (−5.63 to 2.66) | 0.673 | − 6.92 (−10.68 to −3.15) | < 0.0001** |
6 month | 11.7 (8.9) | 19.3 (9.3) | 21.0 (9.2) | − 9.27 (−13.24 to − 5.29) | < 0.0001*** | − 1.66 (− 5.66 to 2.34) | 0.588 | − 7.61 (− 11.52 to − 3.70) | < 0.0001*** |
FABQ activity (0 = best, 24 = worst) | |||||||||
Baseline | 18.7 (4.4) | 18.7 (4.4) | 18.6 (5.2) | ||||||
Post-intervention | 8.5 (5.4) | 12.2 (6.6) | 18.0 (4.9) | −9.44 (−11.71 to −7.17) | < 0.0001*** | −5.81 (−8.30 to −3.31) | < 0.0001** | − 3.63 (−6.21 to − 1.05) | 0.003** |
3 month | 6.5 (6.2) | 13.0 (5.6) | 17.8 (5.2) | −11.31 (− 13.81 to − 8.80) | < 0.0001*** | −4.84 (− 7.15 to − 2.53) | < 0.0001** | −6.47 (− 9.00 to − 3.93) | < 0.0001*** |
6 month | 7.3 (6.2) | 14.6 (5.6) | 18.2 (4.7) | −10.96 (− 13.37 to − 8.54) | < 0.0001*** | −3.62 (− 5.85 to − 1.38) | 0.001* | − 7.34 (− 9.88 to − 4.80) | < 0.0001*** |
HAD Depression (0 = best, 21 = worst) | |||||||||
Baseline | 5.8 (2.4) | 5.6 (3.6) | 6.0 (5.0) | ||||||
Post-intervention | 4.2 (2.0) | 4.9 (3.4) | 6.1 (4.2) | −1.96 (−3.41 to −0.51) | 0.005** | − 1.24 (− 2.89 to 0.41) | 0.177 | −0.72 (− 1.92 to 0.48) | 0.333 |
3 month | 4.0 (2.0) | 4.8 (3.1) | 6.1 (4.1) | −2.04 (−3.49 to −0.60) | 0.003** | − 1.21 (− 2.80 to 0.37) | 0.169 | − 0.83 (− 1.94 to 0.28) | 0.180 |
6 month | 4.2 (2.3) | 4.9 (2.9) | 6.1 (4.1) | − 1.89 (− 3.35 to − 0.42) | 0.008** | −1.17 (− 2.71 to 0.36) | 0.169 | −0.71 (− 1.84 to 0.42) | 0.294 |
HAD Anxiety (0 = best, 21 = worst) | |||||||||
Baseline | 6.3 (2.5) | 6.2 (3.9) | 6.6 (4.3) | ||||||
Post-intervention | 5.1 (2.1) | 5.5 (3.4) | 6.7 (3.3) | −1.69 (−2.92 to −0.46) | 0.004** | −1.22 (− 2.68 to 0.24) | 0.121 | − 0.47 (− 1.69 to 0.75) | 0.627 |
3 month | 4.7 (2.0) | 5.5 (3.1) | 6.5 (3.6) | −1.79 (−3.07 to − 0.52) | 0.003** | −1.00 (− 2.45 to 0.44) | 0.231 | − 0.79 (− 1.90 to 0.32) | 0.215 |
6 month | 4.5 (2.2) | 5.3 (2.9) | 6.6 (3.4) | −2.07 (− 3.33 to − 0.80) | 0.001** | −1.22 (− 2.59 to 0.15) | 0.091 | − 0.85 (− 1.95 to 0.25) | 0.166 |